Why the study?
This study was conducted to provide supporting data to identify factors related to readmission in heart failure patients.
What are the related factors to readmission in heart failure patients discharged from an advanced general hospital?
What are the related factors to readmission in heart failure patients discharged from an advanced general hospital?
The number of discharge medications and lower sodium levels at admission and discharge are significant risk factors for readmission in heart failure patients.
Discharge polypharmacy and lower sodium associate with higher HF readmission; hypothesis-generating and requires prospective validation before practice change.
Objectives: This study was to provide supporting data to identify related factors of heart failure patients readmission. Methods: This study is a retrospective study of secondary data analysis using electronic medical record of patients who were discharged from advanced general hospital diagnosed with heart failure from April 2017 to March 2020. Results: A total of 267 (14.4%) of 1,857 heart failure patients was readmitted. Age, initial body weight, body weight change, pulse rate, hospitalization for 6 months prior or emergency room visit, number of medications, blood sampling result, main diagnosis of ER, and ACEI/ARB medication were found to be significantly related to readmission. As a result of multivariate logistic regression analysis, each increase in the number of discharge medications, the readmission rate increased by 3.0% (OR = 1.030, p < 0.001). For each increase in Na level at admission and discharge, the readmission rate decreased by 5.4% (OR = 0.946, p = 0.021), 6.6% (OR = 0.934, p = 0.028). For each increase in the CRP level, the readmission rate decreased by 1.1% (OR = 0.989, p = 0.049) and AUC was 0.735. Conclusions: Based on the high-risk factors of readmission for heart failure patients identified in this study, patients centered nursing interventions should be developed to promote self-care practices.
No takes yet. Share an insight, caveat, or question.
Park et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: